Cardiol Therapeutics Announces FDA Investigational New Drug Application…

by The Pericarditis Alliance | May 18, 2022 | Press Release, Resources, Treatment

Kiniksa Announces FDA Approval of Arcalyst

by Dona Winnowski | Aug 14, 2021 | Press Release, Resources, Treatment

THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT

by Dona Winnowski | Jul 14, 2021 | Education, Journal, Resources, Treatment

KINIKSA ANNOUNCES FDA APPROVAL OF ARCALYST ® (RILONACEPT) FOR RECURRENT PERICARDITIS

by Dona Winnowski | Mar 18, 2021 | Press Release, Resources, Treatment

PHASE 3 TRIAL OF INTERLEUKIN-1 TRAP RILONACEPT IN RECURRENT PERICARDITIS

by Dona Winnowski | Jan 7, 2021 | Education, Journal, Resources, Treatment

RILONACEPT PREVENTS RECURRENT PERICARDITIS: RHAPSODY

by Dona Winnowski | Nov 17, 2020 | Education, Journal, Resources, Treatment